Clinical Trial Update: Cell Therapy in Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

A Brazilian Ministry of Health-sponsored cell therapy trial for acute myocardial infarction in Phase 2/3 has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Cell therapy product for acute myocardial infarction

Snippet

Sponsor: Ministry of Health, Brazil | Conditions: Acute Myocardial Infarction | Phase 2, Phase 3 | Status: TERMINATED